Transpupillary thermotherapy of subfoveal occult choroidal neovascularization

Adam H. Rogers, Elias Reichel, Adam Martidis, Audina M. Berrocal

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Scopus citations

Abstract

TTT is emerging as a treatment for occult choroidal neovascularization. By penetrating deep in the choroid with infrared light at 810 mm, TTT causes heat-induced damage to the neovascular tissue while limiting injury to the neurosensory retina. Multiple pilot studies have confirmed that TTT is useful in stabilizing the visual acuity in eyes with occult CNV. Recent pilot studies have identified that TTT stabilizes visual acuity in eyes treated with classic CNV. The use of TTT to treat occult CNV is currently under investigation in the TTT4CNV trial.

Original languageEnglish (US)
Title of host publicationAge-Related Macular Degeneration
PublisherCRC Press
Pages259-265
Number of pages7
ISBN (Electronic)9780203909157
ISBN (Print)9780824706821
StatePublished - Jan 1 2002
Externally publishedYes

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Transpupillary thermotherapy of subfoveal occult choroidal neovascularization'. Together they form a unique fingerprint.

  • Cite this

    Rogers, A. H., Reichel, E., Martidis, A., & Berrocal, A. M. (2002). Transpupillary thermotherapy of subfoveal occult choroidal neovascularization. In Age-Related Macular Degeneration (pp. 259-265). CRC Press.